Caduceus Biotechnology Inc.  Caduceus Biotechnology Inc. is a cost-efficient biochip and diagnostic instrument integration company focused on high-sensitivity, blood-based Alzheimer’s disease biomarker testing.  The Company’s proprietary digital Tau protein detection platform integrates magnetic bead chemistry, microwell array biochips, and microfluidic control to enable single-molecule-level digital detection. Leveraging Poisson statistical analysis, the platform achieves sub-2 pg/mL sensitivity, meeting the clinical performance requirements for blood-based Tau detection.  Caduceus’s business model delivers high performance at a significantly lower cost than incumbent solutions. Target customers include hospitals, diagnostic laboratories, pharmaceutical companies, and research institutions. Revenue is generated through diagnostic testing services, sales of biochips and instruments, and recurring licensing or distribution royalties, supporting a scalable and capital-efficient growth model.